Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Kivu Bioscience Inc.
Hoffmann-La Roche
Aveni Foundation
Bayer
University of California, Irvine
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Karyopharm Therapeutics Inc
Dana-Farber Cancer Institute
Kaiser Permanente
AstraZeneca
University of Florida
Essen Biotech
MacroGenics
Avacta Life Sciences Ltd
Institut Curie
Solve Therapeutics
University of Nebraska
Adela, Inc
Perspective Therapeutics
Ocellaris Pharma, Inc.
M.D. Anderson Cancer Center
Tanabe Pharma America, Inc.
HiFiBiO Therapeutics
TScan Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
Hadassah Medical Organization
AVM Biotechnology Inc
Washington University School of Medicine
Institut Bergonié
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Institut Claudius Regaud
Telix Pharmaceuticals (Innovations) Pty Limited
PharmaMar
Institut Bergonié
University of California, Irvine
Cancer Research UK
University Health Network, Toronto
Instituto do Cancer do Estado de São Paulo
Region Skane
Elevation Oncology
University of South Florida
Stanford University